The Possible Role of Glivec in Patients With Tumor Cells Positive for C-kit or Platelet Derived Growth Factor Receptor (PDGFR); a Multi Center Study.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2011
At a glance
- Drugs Imatinib (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 27 Apr 2011 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 22 Oct 2005 New trial record.